Status:
UNKNOWN
HIV-HBV Co-Infection and Liver Disease
Lead Sponsor:
Bayside Health
Collaborating Sponsors:
Centre for Clinical Research Excellence in Infectious Diseases, Parkville
Gilead Sciences
Conditions:
HIV Infections
HIV-HBV Co-Infection
Eligibility:
All Genders
18+ years
Brief Summary
Human immunodeficiency virus/Hepatitis B virus (HIV/HBV) co-infections are frequently observed due to shared routes of transmission, with reported figures indicating 6-9% of HIV-infected individuals i...
Eligibility Criteria
Inclusion
- 18 years of age and older
- HIV positive
- 2 positive Hepatitis B surface antigen results 6 months apart
- provision of informed consent
Exclusion
- unable to provide informed consent
Key Trial Info
Start Date :
November 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT00637429
Start Date
November 1 2007
Last Update
April 2 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Alfred Hospital
Melbourne, Victoria, Australia, 3004